nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

13.08.2019 | Letter to the Editor

To be capsulated or not be capsulated: that is the GAS question

verfasst von: Roberta Creti, Giovanni Gherardi, Monica Imperi

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Excerpt

To the Editor, …

Nur mit Berechtigung zugänglich

Wessels MR (2016) Cell wall and surface molecules: capsule. In: Ferretti JJ, Stevens DL, Fischetti VA (eds) Streptococcus pyogenes : basic biology to clinical manifestations [internet]. University of Oklahoma Health Sciences Center, Oklahoma City (OK) Available from http://www.ncbi.nlm.nih.gov/books/NBK333410/

Wessels MR (2019) Capsular polysaccharide of group a Streptococcus. Microbiol Spectr 7:1. https://doi.org/10.1128/microbiolspec.GPP3-0050-2018 CrossRef

Falaleeva M, Zurek OW, Watkins RL et al (2014) Transcription of the Streptococcus pyogenes hyaluronic acid capsule biosynthesis operon is regulated by previously unknown upstream elements. Infect Immun 82:5293–5307CrossRef

Flores AR, Jewell BE, Fittipaldi N, Beres SB, Musser JM (2012) Human disease isolates of serotype m4 and m22 group a streptococcus lack genes required for hyaluronic acid capsule biosynthesis. MBio 3:e00413–e00412CrossRef

Zhu L, Olsen RJ, Nasser W, de la Riva Morales I, Musser JM (2015) Trading capsule for increased cytotoxin production: contribution to virulence of a newly emerged clade of emm89 Streptococcus pyogenes. MBio 6:e01378–e01315. https://doi.org/10.1128/mBio.01378-15 CrossRefPubMedPubMedCentral

Efstratiou A, Sriskandan S (2015) Emergence of a new highly successful acapsular group A Streptococcus clade of genotype emm89 in the United Kingdom. MBio 6:e00622PubMedPubMedCentral

Flores AR, Chase McNeil J, Shah B, Van Beneden C, Shelburne SA 3rd (2018) Capsule-negative emm types are an increasing cause of pediatric group a streptococcal infections at a large pediatric hospital in Texas. J Pediatric Infect Dis Soc 1. https://doi.org/10.1093/jpids/piy053 CrossRef

Chochua S, Metcalf BJ, Li Z et al (2017) Population and whole genome sequence based characterization of invasive group a streptococci recovered in the United States during 2015. MBio 8:e01422–e01417. https://doi.org/10.1128/mBio.01422-17 CrossRefPubMedPubMedCentral

Davies MR, McIntyre L, Mutreja A et al (2019) Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics. Nat Genet 51:1035–1043. https://doi.org/10.1038/s41588-019-0417-8 CrossRefPubMedPubMedCentral

10.

Stollerman GH (2001) Rheumatic fever in the 21st century. Clin Infect Dis 33:806–814CrossRef

11.

Stollerman GH, Dale JB (2008) The importance of the group a streptococcus capsule in the pathogenesis of human infections: a historical perspective. Clin Infect Dis 46:1038–1045. https://doi.org/10.1086/529194 CrossRefPubMed

12.

Dale JB, Washburn RG, Marques MB, Wessels MR (1996) Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci. Infect Immun 64:1495–1501CrossRef

13.

Cywes C, Wessels MR (2001) Group A Streptococcus tissue invasion by CD44-mediated cell signalling. Nature 414:648–652CrossRef

14.

van de Rijn I (1983) Streptococcal hyaluronic acid: proposed mechanisms of degradation and loss of synthesis during stationary phase. J Bacteriol 156:1059–1065CrossRef

15.

Crater DL, van de Rijn I (1995) Hyaluronic acid synthesis operon (has) expression in group A streptococci. J Biol Chem 270:18452–18458CrossRef

16.

Flores AR, Jewell BE, Olsen RJ et al (2014) Asymptomatic carriage of group A streptococcus is associated with elimination of capsule production. Infect Immun 82:3958–3967CrossRef

17.

Henningham A, Yamaguchi M, Aziz RK et al (2014) Mutual exclusivity of hyaluronan and hyaluronidase in invasive group A Streptococcus. J Biol Chem 289:32303–33215CrossRef

18.

Hynes W, Johnson C, Stokes M (2009) A single nucleotide mutation results in loss of enzymatic activity in the hyaluronate lyase gene of Streptococcus pyogenes. Microb Pathog 47:308–313CrossRef

19.

Nasser W, de la Riva Morales I, Musser JM (2015) Trading capsule for increased cytotoxin production: contribution to virulence of a newly emerged clade of emm89 Streptococcus pyogenes. MBio 6:e01378-15CrossRef

20.

Galloway-Peña J, DebRoy S, Brumlow C et al (2018) Hypervirulent group A Streptococcus emergence in an acaspular background is associated with marked remodeling of the bacterial cell surface. PLoS One 13(12):e0207897. https://doi.org/10.1371/journal.pone.0207897 CrossRefPubMedPubMedCentral

21.

Bernard PE, Kachroo P, Zhu L et al (2018) RocA has serotype-specific gene regulatory and pathogenesis activities in serotype M28 group A Streptococcus. Infect Immun 86(11):e00467-18. https://doi.org/10.1128/IAI.00467-18 CrossRefPubMedPubMedCentral

22.

Bernard PE, Kachroo P, Eraso JM et al (2019) Polymorphisms in RocA Contribute to the Molecular Pathogenesis of Serotype M28 Group A Streptococcus. Am J Pathol. https://doi.org/10.1016/j.ajpath.2019.06.009 CrossRef

23.

Kachroo P, Eraso JM, Beres SB et al (2019) Integrated analysis of population genomics, transcriptomics and virulence provides novel insights into Streptococcus pyogenes pathogenesis. Nat Genet 51:548–559CrossRef

24.

Matysik A, Kline KA (2019) Streptococcus pyogenes capsule promotes microcolony-independent biofilm formation. J Bacteriol. https://doi.org/10.1128/JB.00052-19

Titel: To be capsulated or not be capsulated: that is the GAS question
verfasst von: Roberta Creti
Giovanni Gherardi
Monica Imperi
Publikationsdatum: 13.08.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 12/2019
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-019-03677-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

23.04.2024 | Ablationstherapie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

To be capsulated or not be capsulated: that is the GAS question

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Hinter dieser Appendizitis steckte ein Erreger

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2019

Incidence, clinical characteristics, and outcomes of Streptococcus dysgalactiae subspecies equisimilis bacteremia in a tertiary hospital: comparison with S. agalactiae bacteremia

Duodenoscope-associated infections: a review

Resistance reported from China antimicrobial surveillance network (CHINET) in 2018

The evaluation of the appropriate gentamicin use for preterm infants

Effect of conjugated bilirubin on clinical outcomes in infective endocarditis

Use of other antimicrobial drugs is associated with trimethoprim resistance in patients with urinary tract infections caused by E. coli

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Hinter dieser Appendizitis steckte ein Erreger

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Innere Medizin